Funding for this research was provided by:
Division of Cancer Epidemiology and Genetics, National Cancer Institute (None)
National Health and Medical Research Council (1011618)
Breast Cancer Now (None)
Fondation ARC pour la Recherche sur le Cancer (None)
Victorian Breast Cancer Research Consortium (None)
Cancer Research UK Imperial Centre (None)
Institut National du Cancer (None)
European Commission (EC) Seventh Framework Programme (FP7) Translational Cancer Research (TRANSCAN) Framework (None)
Ligue Nationale (Française) Contre le Cancer (None)
Text and Data Mining valid from 2019-05-17
Received: 15 January 2019
Accepted: 23 April 2019
First Online: 17 May 2019
Ethics approval and consent to participate
: The following Institutional Review Boards (IRBs) have approved the collection of different datasets, which have contributed to this study: Cancer Council Victoria’s Human Research Committee, International Agency for Research on Cancer (IARC), and the US National Cancer Institute and participating individual centers for each study.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.